# Adaptive Biotechnologies Corp > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:74ed1ff5-2763-4c87-86a2-9aa295dfb67d | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/adaptive-biotechnologies-corp | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 22 | | Claims under review | 1 | | Evidence records | 12 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-17T04:45:45.751176+00:00 | | Last reviewed | 2026-10-17T04:45:45.751176+00:00 | ## Identity - Legal name: Adaptive Biotechnologies Corp - Display name: Adaptive Biotechnologies Corp ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-17T10:22:48.65995+00:00 | | Completeness | 0.409 | | Record Quality | 0.831 | | Directors | 4 | | Committees | 4 | | Governance events | 15 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | PUBLISHED | | leadership | PUBLISHED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - Chad Robins: Director. Status: current. Independent: false. Since: 2009-01-01. claim_id=alpha:claim:company:74ed1ff5-2763-4c87-86a2-9aa295dfb67d:leadership_role:5 - Katey Owen, PhD: Director. Status: current. Independent: true. Since: 2021-01-01. claim_id=alpha:claim:company:74ed1ff5-2763-4c87-86a2-9aa295dfb67d:leadership_role:6 - Michelle Griffin: Director. Status: current. Independent: true. Since: 2019-01-01. Committees: Audit (chair); Audit · Chair (member). claim_id=alpha:claim:company:74ed1ff5-2763-4c87-86a2-9aa295dfb67d:leadership_role:7 - Peter Neupert: Director. Status: current. Independent: true. Since: 2013-01-01. Committees: Audit (member); Audit; Nominating and Governance · Chair (member); Nominating and Governance (chair). claim_id=alpha:claim:company:74ed1ff5-2763-4c87-86a2-9aa295dfb67d:leadership_role:8 ## Committees - Audit (audit). Chair: Michelle Griffin. Members: Michelle Griffin (chair, current); Peter Neupert (member, current). committee_id=alpha:committee:adaptive-biotechnologies-corp:audit - Audit · Chair (audit). Chair: NOT_PUBLISHED. Members: Michelle Griffin (member, current). committee_id=alpha:committee:adaptive-biotechnologies-corp:audit-chair - Audit; Nominating and Governance · Chair (audit). Chair: NOT_PUBLISHED. Members: Peter Neupert (member, current). committee_id=alpha:committee:adaptive-biotechnologies-corp:audit-nominating-and-governance-chair - Nominating and Governance (nominating_governance). Chair: Peter Neupert. Members: Peter Neupert (chair, current). committee_id=alpha:committee:adaptive-biotechnologies-corp:nominating-and-governance ## Executive leadership - Chad Robins: Chief Executive Officer and Chairman [CEO]. Status: current. claim_id=alpha:claim:company:74ed1ff5-2763-4c87-86a2-9aa295dfb67d:leadership_role:9 - Francis Lo: Chief People Officer [CHRO]. Status: current. claim_id=alpha:claim:company:74ed1ff5-2763-4c87-86a2-9aa295dfb67d:leadership_role:10 - Harlan Robins: Chief Scientific Officer. Status: current. claim_id=alpha:claim:company:74ed1ff5-2763-4c87-86a2-9aa295dfb67d:leadership_role:11 - Julie Rubinstein: President and Chief Operating Officer [COO]. Status: current. claim_id=alpha:claim:company:74ed1ff5-2763-4c87-86a2-9aa295dfb67d:leadership_role:13 - Kyle Piskel: Chief Financial Officer [CFO]. Status: current. claim_id=alpha:claim:company:74ed1ff5-2763-4c87-86a2-9aa295dfb67d:leadership_role:14 - Sharon Benzeno: Chief Commercial Officer, Immune Medicine. Status: current. claim_id=alpha:claim:company:74ed1ff5-2763-4c87-86a2-9aa295dfb67d:leadership_role:15 - Susan Bobulsky: Chief Commercial Officer, MRD. Status: current. claim_id=alpha:claim:company:74ed1ff5-2763-4c87-86a2-9aa295dfb67d:leadership_role:17 - Harlan Robins, PhD: Chief Scientific Officer. Status: unknown. claim_id=alpha:claim:company:74ed1ff5-2763-4c87-86a2-9aa295dfb67d:leadership_role:12 - Sharon Benzeno, PhD: Chief Commercial Officer, Immune Medicine. Status: unknown. claim_id=alpha:claim:company:74ed1ff5-2763-4c87-86a2-9aa295dfb67d:leadership_role:16 ## Governance events - CEO_CHANGED: Chad Robins executive of Adaptive Biotechnologies Corp, effective 2026-04-24. Effective: 2026-04-24. Detected: 2026-10-17T04:45:45.751176+00:00. event_id=alpha:event:transition:1orofc79l4g6j - EXECUTIVE_APPOINTED: Francis Lo executive of Adaptive Biotechnologies Corp, effective 2026-04-24. Effective: 2026-04-24. Detected: 2026-10-17T04:45:45.751176+00:00. event_id=alpha:event:transition:12cl7ixbirg0d - EXECUTIVE_APPOINTED: Harlan Robins executive of Adaptive Biotechnologies Corp, effective 2026-04-24. Effective: 2026-04-24. Detected: 2026-10-17T04:45:45.751176+00:00. event_id=alpha:event:transition:oe145z3j66fr - EXECUTIVE_APPOINTED: Julie Rubinstein executive of Adaptive Biotechnologies Corp, effective 2026-04-24. Effective: 2026-04-24. Detected: 2026-10-17T04:45:45.751176+00:00. event_id=alpha:event:transition:14xd6ux20wub - CFO_CHANGED: Kyle Piskel executive of Adaptive Biotechnologies Corp, effective 2026-04-24. Effective: 2026-04-24. Detected: 2026-10-17T04:45:45.751176+00:00. event_id=alpha:event:transition:w1chh7xte2ft - EXECUTIVE_APPOINTED: Sharon Benzeno executive of Adaptive Biotechnologies Corp, effective 2026-04-24. Effective: 2026-04-24. Detected: 2026-10-17T04:45:45.751176+00:00. event_id=alpha:event:transition:1j1dkg5cmgc23 - EXECUTIVE_APPOINTED: Susan Bobulsky executive of Adaptive Biotechnologies Corp, effective 2026-04-24. Effective: 2026-04-24. Detected: 2026-10-17T04:45:45.751176+00:00. event_id=alpha:event:transition:9bz2h81vz3acq - DIRECTOR_APPOINTED: Katey Owen, PhD seat on Adaptive Biotechnologies Corp, effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-17T04:45:45.751176+00:00. event_id=alpha:event:transition:wu0welux8q3 - DIRECTOR_APPOINTED: Michelle Griffin seat on Adaptive Biotechnologies Corp, effective 2019-01-01. Effective: 2019-01-01. Detected: 2026-10-17T04:45:45.751176+00:00. event_id=alpha:event:transition:1k6sxxn1x6sur5 - COMMITTEE_CREATED: Audit · Chair committee of Adaptive Biotechnologies Corp, effective 2019-01-01. Effective: 2019-01-01. Detected: 2026-10-17T04:45:45.751176+00:00. event_id=alpha:event:transition:kb2xe1rifd1 - COMMITTEE_MEMBER_ADDED: Michelle Griffin member of Audit · Chair, effective 2019-01-01. Effective: 2019-01-01. Detected: 2026-10-17T04:45:45.751176+00:00. event_id=alpha:event:transition:ribj31ysetl9 - DIRECTOR_APPOINTED: Peter Neupert seat on Adaptive Biotechnologies Corp, effective 2013-01-01. Effective: 2013-01-01. Detected: 2026-10-17T04:45:45.751176+00:00. event_id=alpha:event:transition:m6g2pk92jr1s - COMMITTEE_CREATED: Audit; Nominating and Governance · Chair committee of Adaptive Biotechnologies Corp, effective 2013-01-01. Effective: 2013-01-01. Detected: 2026-10-17T04:45:45.751176+00:00. event_id=alpha:event:transition:17kaxkg1mbpwd4 - COMMITTEE_MEMBER_ADDED: Peter Neupert member of Audit; Nominating and Governance · Chair, effective 2013-01-01. Effective: 2013-01-01. Detected: 2026-10-17T04:45:45.751176+00:00. event_id=alpha:event:transition:11e6necva8dne - DIRECTOR_APPOINTED: Chad Robins seat on Adaptive Biotechnologies Corp, effective 2009-01-01. Effective: 2009-01-01. Detected: 2026-10-17T04:45:45.751176+00:00. event_id=alpha:event:transition:29ibhg1vty06a ## Scoped resources - `alpha://company/adaptive-biotechnologies-corp` (contract): https://registry.alpha.ac/api/public/companies/adaptive-biotechnologies-corp?format=record - `alpha://company/adaptive-biotechnologies-corp/identity` (contract): https://registry.alpha.ac/api/public/companies/adaptive-biotechnologies-corp?format=record§ion=identity - `alpha://company/adaptive-biotechnologies-corp/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/adaptive-biotechnologies-corp?format=record§ion=corporate-structure - `alpha://company/adaptive-biotechnologies-corp/board` (contract): https://registry.alpha.ac/api/public/companies/adaptive-biotechnologies-corp?format=record§ion=board - `alpha://company/adaptive-biotechnologies-corp/committees` (contract): https://registry.alpha.ac/api/public/companies/adaptive-biotechnologies-corp?format=record§ion=committees - `alpha://company/adaptive-biotechnologies-corp/leadership` (contract): https://registry.alpha.ac/api/public/companies/adaptive-biotechnologies-corp?format=record§ion=leadership - `alpha://company/adaptive-biotechnologies-corp/ownership` (contract): https://registry.alpha.ac/api/public/companies/adaptive-biotechnologies-corp?format=record§ion=ownership - `alpha://company/adaptive-biotechnologies-corp/financials` (contract): https://registry.alpha.ac/api/public/companies/adaptive-biotechnologies-corp?format=record§ion=financials - `alpha://company/adaptive-biotechnologies-corp/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/adaptive-biotechnologies-corp?format=record§ion=capital-structure - `alpha://company/adaptive-biotechnologies-corp/compensation` (contract): https://registry.alpha.ac/api/public/companies/adaptive-biotechnologies-corp?format=record§ion=compensation - `alpha://company/adaptive-biotechnologies-corp/governance` (contract): https://registry.alpha.ac/api/public/companies/adaptive-biotechnologies-corp?format=record§ion=governance - `alpha://company/adaptive-biotechnologies-corp/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/adaptive-biotechnologies-corp?format=record§ion=shareholder-governance - `alpha://company/adaptive-biotechnologies-corp/audit` (contract): https://registry.alpha.ac/api/public/companies/adaptive-biotechnologies-corp?format=record§ion=audit - `alpha://company/adaptive-biotechnologies-corp/legal` (contract): https://registry.alpha.ac/api/public/companies/adaptive-biotechnologies-corp?format=record§ion=legal - `alpha://company/adaptive-biotechnologies-corp/risk` (contract): https://registry.alpha.ac/api/public/companies/adaptive-biotechnologies-corp?format=record§ion=risk - `alpha://company/adaptive-biotechnologies-corp/cyber` (contract): https://registry.alpha.ac/api/public/companies/adaptive-biotechnologies-corp?format=record§ion=cyber - `alpha://company/adaptive-biotechnologies-corp/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/adaptive-biotechnologies-corp?format=record§ion=ai-governance - `alpha://company/adaptive-biotechnologies-corp/agents` (contract): https://registry.alpha.ac/api/public/companies/adaptive-biotechnologies-corp?format=record§ion=agents - `alpha://company/adaptive-biotechnologies-corp/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/adaptive-biotechnologies-corp?format=record§ion=ecosystem - `alpha://company/adaptive-biotechnologies-corp/events` (contract): https://registry.alpha.ac/api/public/companies/adaptive-biotechnologies-corp?format=record§ion=events - `alpha://company/adaptive-biotechnologies-corp/relationships` (contract): https://registry.alpha.ac/api/public/companies/adaptive-biotechnologies-corp?format=record§ion=relationships - `alpha://company/adaptive-biotechnologies-corp/assessments` (contract): https://registry.alpha.ac/api/public/companies/adaptive-biotechnologies-corp?format=record§ion=assessments - `alpha://company/adaptive-biotechnologies-corp/evidence` (contract): https://registry.alpha.ac/api/public/companies/adaptive-biotechnologies-corp?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - Claim alpha:claim:company:74ed1ff5-2763-4c87-86a2-9aa295dfb67d:committee_appointment:19: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"chair","person":{"alpha_id":"alpha:person:michelle-griffin","name":"Michelle Griffin"},"source_id":"board_seats"}` - Claim alpha:claim:company:74ed1ff5-2763-4c87-86a2-9aa295dfb67d:committee_appointment:20: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:peter-neupert","name":"Peter Neupert"},"source_id":"board_seats"}` - Claim alpha:claim:company:74ed1ff5-2763-4c87-86a2-9aa295dfb67d:committee_appointment:22: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"chair","person":{"alpha_id":"alpha:person:peter-neupert","name":"Peter Neupert"},"source_id":"board_seats"}` ## Leadership - Chad Robins: Director. Claim: alpha:claim:company:74ed1ff5-2763-4c87-86a2-9aa295dfb67d:leadership_role:5. Valid from: 2009-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:3d18a55a897135708ae14d9762a09b7ddcb0432b74d60ea3245558bdd8280584. - Katey Owen, PhD: Director. Claim: alpha:claim:company:74ed1ff5-2763-4c87-86a2-9aa295dfb67d:leadership_role:6. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:3d18a55a897135708ae14d9762a09b7ddcb0432b74d60ea3245558bdd8280584. - Michelle Griffin: Director, Audit · Chair. Claim: alpha:claim:company:74ed1ff5-2763-4c87-86a2-9aa295dfb67d:leadership_role:7. Valid from: 2019-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:3d18a55a897135708ae14d9762a09b7ddcb0432b74d60ea3245558bdd8280584. - Peter Neupert: Director, Audit; Nominating and Governance · Chair. Claim: alpha:claim:company:74ed1ff5-2763-4c87-86a2-9aa295dfb67d:leadership_role:8. Valid from: 2013-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:3d18a55a897135708ae14d9762a09b7ddcb0432b74d60ea3245558bdd8280584. - Chad Robins: Chief Executive Officer and Chairman. Claim: alpha:claim:company:74ed1ff5-2763-4c87-86a2-9aa295dfb67d:leadership_role:9. Valid from: 2026-04-24. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:4d5be2b161a7a9de4eef33e8a9cbaf8da81e4f8e9a8f4627e7dc32cf2963df60. - Francis Lo: Chief People Officer. Claim: alpha:claim:company:74ed1ff5-2763-4c87-86a2-9aa295dfb67d:leadership_role:10. Valid from: 2026-04-24. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:5fb47e3d33eff5de597293759fda4fbdeec9ebcbf56c554596cdd5c2f335d3a8. - Harlan Robins: Chief Scientific Officer. Claim: alpha:claim:company:74ed1ff5-2763-4c87-86a2-9aa295dfb67d:leadership_role:11. Valid from: 2026-04-24. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:d76087586a44c9d67d4db1439b21ca67577168cacdb4542126728c6fdb63fae7. - Harlan Robins, PhD: Chief Scientific Officer. Claim: alpha:claim:company:74ed1ff5-2763-4c87-86a2-9aa295dfb67d:leadership_role:12. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:58cf0f4d03b2ebe5d3cf53becef8febc1212c6aa858933f3f4efea36a41bc971. - Julie Rubinstein: President and Chief Operating Officer. Claim: alpha:claim:company:74ed1ff5-2763-4c87-86a2-9aa295dfb67d:leadership_role:13. Valid from: 2026-04-24. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:d8604e0b7f98cb231a38f886e735c589a6129b92889d476f8d52fdec29d2f14c. - Kyle Piskel: Chief Financial Officer. Claim: alpha:claim:company:74ed1ff5-2763-4c87-86a2-9aa295dfb67d:leadership_role:14. Valid from: 2026-04-24. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:16deaf7176c11c6a502da50acf5614746b52e63bca92a732a98ef0ac3713f432. - Sharon Benzeno: Chief Commercial Officer, Immune Medicine. Claim: alpha:claim:company:74ed1ff5-2763-4c87-86a2-9aa295dfb67d:leadership_role:15. Valid from: 2026-04-24. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:ab1c2660c3fce643ec85f363c3b819033cfea0969d995105522ed16f0c581729. - Sharon Benzeno, PhD: Chief Commercial Officer, Immune Medicine. Claim: alpha:claim:company:74ed1ff5-2763-4c87-86a2-9aa295dfb67d:leadership_role:16. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:e58ebb5bfec80433810c7de7a3919ba83207a41e30e8b61e7a095d69a4773210. - Susan Bobulsky: Chief Commercial Officer, MRD. Claim: alpha:claim:company:74ed1ff5-2763-4c87-86a2-9aa295dfb67d:leadership_role:17. Valid from: 2026-04-24. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:dd919ba99145600129115f6dcf346cb43d31235c5128e6a84c4158671e2e8be6. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - Audit: Chair Michelle Griffin; Members Michelle Griffin (Chair); Peter Neupert. Claim: alpha:claim:company:74ed1ff5-2763-4c87-86a2-9aa295dfb67d:committee_record:18. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:eb1d265dbcb2f63cf3738cf138679e725b52dc4d3eb85f922e20881d772d15b4. - Nominating and Governance: Chair Peter Neupert; Members Peter Neupert (Chair). Claim: alpha:claim:company:74ed1ff5-2763-4c87-86a2-9aa295dfb67d:committee_record:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:eb1d265dbcb2f63cf3738cf138679e725b52dc4d3eb85f922e20881d772d15b4. ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - Adaptive Biotechnologies Corp. Claim: alpha:claim:company:74ed1ff5-2763-4c87-86a2-9aa295dfb67d:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:ee6ff80cd0b23209e56f82382939f0360ed22e6151d6e07e62821ed6a992176b. ## Entity Status - Public listing published. Claim: alpha:claim:company:74ed1ff5-2763-4c87-86a2-9aa295dfb67d:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:ee6ff80cd0b23209e56f82382939f0360ed22e6151d6e07e62821ed6a992176b. ## Published Fact - US. Claim: alpha:claim:company:74ed1ff5-2763-4c87-86a2-9aa295dfb67d:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:ee6ff80cd0b23209e56f82382939f0360ed22e6151d6e07e62821ed6a992176b. ## Committee Appointment - Michelle Griffin: chair, Audit. Claim: alpha:claim:company:74ed1ff5-2763-4c87-86a2-9aa295dfb67d:committee_appointment:19. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:eb1d265dbcb2f63cf3738cf138679e725b52dc4d3eb85f922e20881d772d15b4. - Peter Neupert: member, Audit. Claim: alpha:claim:company:74ed1ff5-2763-4c87-86a2-9aa295dfb67d:committee_appointment:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:eb1d265dbcb2f63cf3738cf138679e725b52dc4d3eb85f922e20881d772d15b4. - Peter Neupert: chair, Nominating and Governance. Claim: alpha:claim:company:74ed1ff5-2763-4c87-86a2-9aa295dfb67d:committee_appointment:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:eb1d265dbcb2f63cf3738cf138679e725b52dc4d3eb85f922e20881d772d15b4. ## Security Listing - ADPT (NASDAQ). Claim: alpha:claim:company:74ed1ff5-2763-4c87-86a2-9aa295dfb67d:security_listing:23. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:ee6ff80cd0b23209e56f82382939f0360ed22e6151d6e07e62821ed6a992176b. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:ee6ff80cd0b23209e56f82382939f0360ed22e6151d6e07e62821ed6a992176b: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/adaptive-biotechnologies-corp). - alpha:projection-evidence:document:3d18a55a897135708ae14d9762a09b7ddcb0432b74d60ea3245558bdd8280584: [Adaptive Biotechnologies Corp DEF 14A 2025-04-29](https://www.sec.gov/Archives/edgar/data/1478320/000119312525103752/d865351ddef14a.htm). - alpha:projection-evidence:document:4d5be2b161a7a9de4eef33e8a9cbaf8da81e4f8e9a8f4627e7dc32cf2963df60: [ADPT DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1478320/000119312526177409/adpt-20260423.htm). - alpha:projection-evidence:document:5fb47e3d33eff5de597293759fda4fbdeec9ebcbf56c554596cdd5c2f335d3a8: [ADPT DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1478320/000119312526177409/adpt-20260423.htm). - alpha:projection-evidence:document:d76087586a44c9d67d4db1439b21ca67577168cacdb4542126728c6fdb63fae7: [ADPT DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1478320/000119312526177409/adpt-20260423.htm). - alpha:projection-evidence:document:58cf0f4d03b2ebe5d3cf53becef8febc1212c6aa858933f3f4efea36a41bc971: ADPT executive roster source. - alpha:projection-evidence:document:d8604e0b7f98cb231a38f886e735c589a6129b92889d476f8d52fdec29d2f14c: [ADPT DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1478320/000119312526177409/adpt-20260423.htm). - alpha:projection-evidence:document:16deaf7176c11c6a502da50acf5614746b52e63bca92a732a98ef0ac3713f432: [ADPT DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1478320/000119312526177409/adpt-20260423.htm). - alpha:projection-evidence:document:ab1c2660c3fce643ec85f363c3b819033cfea0969d995105522ed16f0c581729: [ADPT DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1478320/000119312526177409/adpt-20260423.htm). - alpha:projection-evidence:document:e58ebb5bfec80433810c7de7a3919ba83207a41e30e8b61e7a095d69a4773210: ADPT executive roster source. - alpha:projection-evidence:document:dd919ba99145600129115f6dcf346cb43d31235c5128e6a84c4158671e2e8be6: [ADPT DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1478320/000119312526177409/adpt-20260423.htm). - alpha:projection-evidence:eb1d265dbcb2f63cf3738cf138679e725b52dc4d3eb85f922e20881d772d15b4: [Audit](https://www.sec.gov/Archives/edgar/data/1478320/000119312525103752/d865351ddef14a.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/adaptive-biotechnologies-corp) - [Public Markdown](https://registry.alpha.ac/companies/adaptive-biotechnologies-corp.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/adaptive-biotechnologies-corp?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/adaptive-biotechnologies-corp?format=jsonld) - MCP resource: `alpha://companies/adaptive-biotechnologies-corp` at https://mcp.alpha.ac/mcp ## Connected governance records Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage. ## Critical-risk oversight Snapshot as of 2026-10-17T10:22:48.431981+00:00; recorded 2026-10-17T10:22:48.431981+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.